FDA Adverse Event Injury Summary report: N

ISPAN PERFLUOROPROPANE (C3F8) GAS

MDR report key: 14490394 · Received May 24, 2022

Report

Report Number
1610287-2022-00033
Event Type
Injury
Date Received
May 24, 2022
Date of Event
January 12, 2022
Report Date
July 29, 2022
Manufacturer
AIRGAS THERAPEUTICS LLC
Product Code
LPO
UDI-DI
00380657971022
PMA / PMN Number
P900066
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION INCLUDING ROOT CAUSE ANALYSIS IS IN PROGRESS. A SUPPLEMENTAL MDR WILL BE FILED AS NECESSARY IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL REPORTABLE INFORMATION BECOMES AVAILABLE. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Additional Manufacturer Narrative · 0

A CHECK OF THE BATCH PRODUCTION RECORD FOR THIS LOT SHOWED NO UNUSUAL MANUFACTURING ISSUES. A CHECK OF THE COMPLAINT RECORDS SHOWED TWO OTHER COMPLAINT AGAINST THIS LOT. A CHECK OF CONFIRMED COMPLAINTS FOR THIS EVENT, SHOWED NO COMPLAINTS. THE SAMPLE WAS NOT RETURNED, THEREFORE; TESTING COULD NOT BE PERFORMED. NO SAMPLE WAS RETURNED FOR EVALUATION. AN ANALYSIS OF THE RETAIN SAMPLES FOR THIS LOT, SHOWED THAT THE PRODUCT MET ALL RELEASE CRITERIA. BASED UPON THE INFORMATION OBTAINED THE REPORTED EVENT CANNOT BE DETERMINED CONCLUSIVELY. THE ROOT CAUSE OF THE REPORTED EVENT CANNOT BE DETERMINED. THE MANUFACTURER WILL CONTINUE TO MONITOR DATA FOR EVIDENCE OF ADVERSE TRENDING AND TAKE FURTHER ACTION, AS APPROPRIATE. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Description of Event or Problem · 0

A CLINICAL STUDY REPORTED THAT AFTER USING PERFLUOROPROPANE GAS IN A SURGERY, A PATIENT EXPERIENCED OCULAR HYPERTENSION. THE SEVERITY WAS MILD. MEDICAL TREATMENT WAS PROVIDED AND ALL THE SYMPTOMS WERE RESOLVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1517960 ISPAN PERFLUOROPROPANE (C3F8) GAS INTRAOCULAR GAS LPO AIRGAS THERAPEUTICS LLC NA 034914 00380657971022

Patients

Seq Age Sex Outcome Treatment
1 Unknown Other| R